Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Nov 30, 2025 → Feb 28, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| GUBRA A/S | 0 | 4,545 | 4,545 | 0.51% | $281.03K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS INC | 6,135 | 0 | -6,135 | 0.00% | -$264.54K |
| UNIQURE N.V. | 6,455 | 0 | -6,455 | 0.00% | -$177.58K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| LILLY ELI and CO | 5,210 | 5,263 | 53 | 10.02% | -$66.58K |
| Roche Holding AG | 48,754 | 50,740 | 1,986 | 5.47% | $689.66K |
| JOHNSON&JOHNSON | 7,863 | 10,810 | 2,947 | 4.86% | $1.06M |
| ASTRAZENECA PLC | 12,208 | 12,706 | 498 | 4.82% | $403.15K |
| MERCK & CO | 12,963 | 18,918 | 5,955 | 4.24% | $983.52K |
| THERMO FISHER SCIENTIFIC INC | 3,186 | 4,137 | 951 | 3.90% | $273.45K |
| UNITEDHEALTH GRP | 6,577 | 7,253 | 676 | 3.85% | -$41.81K |
| Novartis AG (Registered) | 11,319 | 11,781 | 462 | 3.62% | $527.08K |
| ABBOTT LABS | 15,393 | 16,017 | 624 | 3.37% | -$120.58K |
| VERTEX PHARMACEUTICALS INC | 3,154 | 3,568 | 414 | 3.21% | $405.08K |
| ABBVIE INC | 6,769 | 7,045 | 276 | 2.96% | $93.70K |
| DANAHER CORP | 6,092 | 7,657 | 1,565 | 2.92% | $231.33K |
| BOSTON SCIENTIFIC CORP | 17,053 | 17,749 | 696 | 2.47% | -$368.23K |
| BRIDGEBIO PHARMA INC | 15,436 | 18,567 | 3,131 | 2.23% | $122.79K |
| BRISTOL-MYERS SQUIBB CO | 18,439 | 19,189 | 750 | 2.17% | $289.62K |
| MCKESSON CORP | 1,168 | 1,210 | 42 | 2.16% | $165.57K |
| NOVO NORDISK-B | 25,819 | 31,589 | 5,770 | 2.15% | -$83.24K |
| CHUGAI PHARMA CO | 16,311 | 16,971 | 660 | 2.06% | $261.76K |
| EDWARDS LIFESCIENCES CORP | 9,702 | 11,887 | 2,185 | 1.86% | $187.00K |
| TEVA PHARMACEUTICAL IND ADR | 9,762 | 26,392 | 16,630 | 1.62% | $631.13K |
| INTUITIVE SURGICAL INC | 1,550 | 1,610 | 60 | 1.47% | -$78.24K |
| MASIMO CORP | 4,118 | 4,286 | 168 | 1.36% | $165.02K |
| DEXCOM INC | 7,334 | 9,698 | 2,364 | 1.29% | $246.64K |
| MADRIGAL PHARMACEUTICALS INC | 1,491 | 1,551 | 60 | 1.21% | -$220.07K |
| INSMED INC | 3,959 | 4,417 | 458 | 1.19% | -$162.97K |
| INSULET CORP | 2,246 | 2,336 | 90 | 1.04% | -$158.79K |
| VIKING THERAPEUTICS INC | 9,221 | 13,867 | 4,646 | 0.85% | $129.83K |
| ZEALAND PHARMA A | 5,153 | 5,363 | 210 | 0.56% | -$104.90K |
| INTELLIA THERAPEUTICS INC | 13,524 | 14,076 | 552 | 0.35% | $72.39K |
| Security | Shares Nov 2025 | Shares Feb 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| GILEAD SCIENCES INC | 15,449 | 13,435 | -2,014 | 3.62% | $57.04K |
| MEDTRONIC PLC | 15,434 | 13,377 | -2,057 | 2.37% | -$319.27K |
| REVOLUTION MEDICINES INC | 13,975 | 11,995 | -1,980 | 2.22% | $137.03K |
| AMGEN INC | 3,239 | 2,984 | -255 | 2.10% | $39.32K |
| REGENERON PHARMACEUTICALS INC | 1,618 | 1,426 | -192 | 2.02% | -$147.69K |
| CYTOKINETICS INC | 14,950 | 13,108 | -1,842 | 1.48% | -$202.96K |
| ALNYLAM PHARMACEUTICALS INC | 2,019 | 1,972 | -47 | 1.19% | -$254.52K |
| ARROWHEAD PHARMACEUTICALS INC | 24,089 | 8,970 | -15,119 | 1.03% | -$701.96K |
| IONIS PHARMACEUTICALS INC | 11,318 | 5,673 | -5,645 | 0.83% | -$475.97K |
| SCHOLAR ROCK HOLDING CORP | 12,243 | 9,773 | -2,470 | 0.78% | -$106.78K |
| Ascendis Pharma A/S | 2,569 | 1,777 | -792 | 0.75% | -$130.55K |
| CRINETICS PHARMACEUTICALS INC | 20,493 | 8,655 | -11,838 | 0.64% | -$577.94K |
| FIRST AM-TR OB-X | 352,581 | 325,513 | -27,068 | 0.59% | -$27.07K |
| NEUROCRINE BIOSCIENCES INC | 3,372 | 2,387 | -985 | 0.57% | -$197.40K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.